Osteoporosis is metabolic skeletal disease defined as a reduction of bone mineral density (BMD) below a defined lower limit of normal.
The World Health Organisation (WHO) defines osteoporosis as a T score less than -2.5 SD. However, Z scores are more reliable than T scores (which are defined against adult white females) as it compares with normal people of same age and gender.
Non-specific features predominate. Osteoporosis is often diagnosed in asymptomatic patients evaluated on the basis of risk factors or following presentation with pathological fractures.
Osteoporosis is essentially decreased bony tissue per unit volume of bone. There is no microstructural and biochemical change as occurs in osteomalacia or rickets. Hence the mineral-to-osteoid ratio is normal (cf. osteomalacia in which the mineral-to-osteoid ratio is decreased).
Osteoporosis can be localised or diffuse and be divided into:
primary: no cause is identifiable (i.e. involutional or age-related osteoporosis) of which there are two types
- postmenopausal: occurs in 50-65 year old females; disproportionate loss of cancellous bone as compared to cortical bone resulting in more involvement of cancellous bone rich areas, like vertebrae and ends of long bones
- senile: occurs in the elderly; proportionate loss of cortical and cancellous bones affecting long bones
- juvenile: juvenile osteoporosis
secondary: occurs due a range of causes including
- endocrine disease
- medications (e.g. steroids), etc
- thalassaemia major 4
Decreased bone density can be appreciated by decreased cortical thickness and loss of bony trabeculae in the early stages in radiography. Bones like vertebra, long bones (proximal femur), calcaneum and tubular bones are usually looked at for evidence of osteoporosis.
- not a sensitive modality, as more than 30-50% bone loss is required to appreciate decreased bone density on a radiograph
- vertebral osteoporosis manifests as:
- loss of trabeculae in proximal femur area which is explained by Singh's index (which can also be seen in the calcaneum
- in tubular bones (especially metacarpals), there will be thinning of cortex
- cortical thickness <25% of whole thickness of metacarpal signifies osteoporosis (normally 25-33%)
Bone mineral density measurement
BMD is the method of estimation of calcium hydroxyapatite. Multiple x-ray based, gamma-ray based and ultrasonic methods are available:
- radiographic absorptiometry (RA)
- single photon and x-ray absorptiometry (SPA)
dual energy x-ray absorptiometry (DEXA)
- most commonly-used and most reliable
- quantitative computed tomography can be used
Treatment and prognosis
As osteoporosis decreases bone strength, patients are at an increased risk of fracture, often with minimal trauma, and commonly at the pelvis, hip and wrist.
Oral bisphosphonates are the most commonly prescribed medication but they have their own complications including bisphosphonate-related atypical femoral fractures and bisphosphonate-related osteonecrosis of the jaw. There are a range of other medications that can also be used.
- 1. Textbook of radiology and imaging. Churchill Livingstone. ISBN:0443071098. Read it at Google Books - Find it at Amazon
- 2. Anil G, Guglielmi G, Peh WC. Radiology of osteoporosis. Radiol. Clin. North Am. 2010;48 (3): 497-518. doi:10.1016/j.rcl.2010.02.016 - Pubmed citation
- 3. Hodsman PM. Diagnosis and management of involutional osteoporosis. Can Fam Physician. 2013;25: 467-72. Free text at pubmed - Pubmed citation
- 4. Toumba M, Skordis N. Osteoporosis syndrome in thalassaemia major: an overview. Journal of osteoporosis. 2010: 537673. doi:10.4061/2010/537673 - Pubmed
Metabolic bone disease
- bone mineralisation
- osteosclerosis (differential diagnosis / mnemonic)
- pituitary gland-related
- thyroid gland-related